Zum Inhalt springen

59. Journal Club 14.06.2023

Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study

Annemarie B. van der Aart-van der Beek PharmD, Ellen Apperloo MD, Niels Jongs PhD, Dennis B. Rouw MD, C. David Sjöström MD, Iris Friedli PhD, Lars Johansson PhD, Daniël H. van Raalte… Weiterlesen »Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study

Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment

Abstract Importance  The association between statin-induced reduction in low-density lipoprotein cholesterol (LDL-C) levels and the absolute risk reduction of individual, rather than composite, outcomes, such… Weiterlesen »Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment